M. Bayés

468 total citations
15 papers, 352 citations indexed

About

M. Bayés is a scholar working on Clinical Psychology, Oncology and Infectious Diseases. According to data from OpenAlex, M. Bayés has authored 15 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Psychology, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in M. Bayés's work include Cancer Treatment and Pharmacology (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Management and Organizational Studies (1 paper). M. Bayés is often cited by papers focused on Cancer Treatment and Pharmacology (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Management and Organizational Studies (1 paper). M. Bayés collaborates with scholars based in United States. M. Bayés's co-authors include Elizabeth F. Howell, Peter M. Newton, J. Castañer, X Rabasseda, Dolors Fernández‐Forner, L.A. Sorbera and J. Bolós and has published in prestigious journals such as Journal of Consulting and Clinical Psychology, Psychiatry and The Journal of Applied Behavioral Science.

In The Last Decade

M. Bayés

15 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bayés United States 8 112 97 95 44 40 15 352
Melinda Jones United States 11 80 0.7× 110 1.1× 73 0.8× 42 1.0× 32 0.8× 30 303
Wendy E. O'connor Canada 7 92 0.8× 116 1.2× 136 1.4× 49 1.1× 24 0.6× 10 336
Diana I. Ríos United States 9 144 1.3× 204 2.1× 72 0.8× 33 0.8× 35 0.9× 12 374
Amy S. Ebesu Hubbard United States 12 133 1.2× 143 1.5× 81 0.9× 18 0.4× 24 0.6× 25 343
John G. Wirtz United States 9 158 1.4× 143 1.5× 74 0.8× 50 1.1× 27 0.7× 12 419
Roger L. Gould United States 4 122 1.1× 110 1.1× 99 1.0× 49 1.1× 38 0.9× 7 463
Kirsten Weber United States 9 138 1.2× 154 1.6× 64 0.7× 20 0.5× 55 1.4× 34 448
Bill Puka United States 10 105 0.9× 96 1.0× 44 0.5× 22 0.5× 45 1.1× 21 302
Osamu Fukushima Japan 8 170 1.5× 211 2.2× 45 0.5× 69 1.6× 60 1.5× 15 354
Gina Castle Bell United States 10 119 1.1× 135 1.4× 56 0.6× 41 0.9× 23 0.6× 15 306

Countries citing papers authored by M. Bayés

Since Specialization
Citations

This map shows the geographic impact of M. Bayés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bayés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bayés more than expected).

Fields of papers citing papers by M. Bayés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bayés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bayés. The network helps show where M. Bayés may publish in the future.

Co-authorship network of co-authors of M. Bayés

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bayés. A scholar is included among the top collaborators of M. Bayés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bayés. M. Bayés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bolós, J., et al.. (2007). Cediranib. Drugs of the Future. 32(7). 577–577. 1 indexed citations
2.
Fernández‐Forner, Dolors, et al.. (2006). Icatibant acetate. Drugs of the Future. 31(2). 101–101. 5 indexed citations
3.
Castañer, J., et al.. (2005). Maraviroc. Drugs of the Future. 30(5). 469–469. 4 indexed citations
4.
Sorbera, L.A., J. Castañer, & M. Bayés. (2005). Darunavir. Drugs of the Future. 30(5). 441–441. 4 indexed citations
5.
Bayés, M., et al.. (2004). Ospemifene. Drugs of the Future. 29(1). 38–38. 1 indexed citations
6.
Castañer, J., et al.. (2002). Erlotinib Hydrochloride. Drugs of the Future. 27(10). 923–923. 9 indexed citations
7.
Castañer, J., et al.. (2002). Lumiracoxib. Drugs of the Future. 27(8). 740–740. 8 indexed citations
8.
Bayés, M., et al.. (2002). Gateways to Clinical Trials. June 2002.. PubMed. 24(5). 291–327. 7 indexed citations
9.
Bayés, M.. (1989). The effects of relocation on the trailing spouse. Smith College Studies in Social Work. 59(3). 280–288. 10 indexed citations
10.
Howell, Elizabeth F. & M. Bayés. (1981). Women and mental health. Basic Books. 146 indexed citations
11.
Bayés, M., et al.. (1978). Problems for paraprofessionals in mental health services. Administration and Policy in Mental Health and Mental Health Services Research. 6(2). 133–146. 8 indexed citations
12.
Bayés, M. & Peter M. Newton. (1978). Women in Authority: A Sociopsychological Analysis. The Journal of Applied Behavioral Science. 14(1). 7–20. 38 indexed citations
13.
Bayés, M., et al.. (1977). The Mental Health Center and the Women’s Liberation Group: An Intergroup Encounter. Psychiatry. 40(1). 66–78. 3 indexed citations
14.
Bayés, M.. (1972). Behavioral cues of interpersonal warmth.. Journal of Consulting and Clinical Psychology. 39(2). 333–339. 103 indexed citations
15.
Bayés, M.. (1970). An Investigation Of The Behavioral Cues Of Interpersonal Warmth. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026